WisdomTree BioRevolution Fund (BATS:WDNA) Shares Down 4.7% – Time to Sell?

WisdomTree BioRevolution Fund (BATS:WDNA) traded down 4.7% during mid-day trading on Thursday . The company traded as low as $14.52 and last traded at $14.52. 1,860 shares were traded during trading, The stock had previously closed at $15.23.

WisdomTree BioRevolution Fund Price Performance

The stock has a market cap of $2.19 million, a price-to-earnings ratio of 16.21 and a beta of 1.20. The stock’s 50-day moving average is $15.74 and its 200-day moving average is $16.12.

Hedge Funds Weigh In On WisdomTree BioRevolution Fund

An institutional investor recently bought a new position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC acquired a new stake in shares of WisdomTree BioRevolution Fund (BATS:WDNA) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 13,134 shares of the company’s stock, valued at approximately $217,000. Jane Street Group LLC owned about 8.76% of WisdomTree BioRevolution Fund at the end of the most recent reporting period.

WisdomTree BioRevolution Fund Company Profile

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.